These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6243941)

  • 1. Mapping cyclic AMP binding sites on type I and type II cyclic AMP-dependent protein kinases using 2-substituted derivatives of cyclic AMP.
    Yagura TS; Sigman CC; Sturm PA; Reist EJ; Johnson HL; Miller JP
    Biochem Biophys Res Commun; 1980 Jan; 92(2):463-7. PubMed ID: 6243941
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of cyclic AMP-dependent protein kinases I and II by cyclic 3',5'-phosphates of 9-beta-d-ribofuranosylpurine and 2-beta-D-ribofuranosylbenzimidazole.
    Yagura TS; Kazimierczuk Z; Shugar D; Miller JP
    Biochem Biophys Res Commun; 1980 Nov; 97(2):737-43. PubMed ID: 6258595
    [No Abstract]   [Full Text] [Related]  

  • 3. Mapping adenosine cyclic 3',5'-phosphate binding sites on type I and type II adenosine cyclic 3',5'-phosphate dependent protein kinases using ribose ring and cyclic phosphate ring analogues of adenosine cyclic 3',5'-phosphate.
    Yagura TS; Miller JP
    Biochemistry; 1981 Feb; 20(4):879-87. PubMed ID: 6260142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP derivatives as tools for mapping cyclic AMP binding sites of cyclic AMP-dependent protein kinases I and II.
    Miller JP
    Adv Cyclic Nucleotide Res; 1981; 14():335-44. PubMed ID: 6269386
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of activation of protein kinase I from rabbit skeletal muscle. Investigation with agarose-immobilized cAMP derivatives.
    Rieke E; Hoppe J; Wagner KG
    Eur J Biochem; 1978 Feb; 83(2):419-26. PubMed ID: 204480
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of type I and type II cyclic AMP-dependent protein kinases by 2,8-disubstituted derivatives of cyclic AMP.
    Yagura TS; Miller JP
    Biochim Biophys Acta; 1980 Jul; 630(3):463-7. PubMed ID: 6249386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of the interaction between cyclic AMP and the regulatory moiety of protein kinase II. Evidence for interaction between the binding sites for cyclic AMP.
    Ogreid D; Døskeland SO
    FEBS Lett; 1981 Jul; 129(2):282-6. PubMed ID: 6269881
    [No Abstract]   [Full Text] [Related]  

  • 8. The 3'-amido and 5'-amido analogues of adenosine 3':5'-monophosphate; interaction with cAMP-specific proteins.
    Panitz N; Rieke E; Morr M; Wagner KG; Roesler G; Jastorff B
    Eur J Biochem; 1975 Jul; 55(2):415-22. PubMed ID: 172331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of purified muscle protein kinase by cyclic AMP and its butyrated derivatives.
    Rebhun LI; Villar-Palasi C
    Biochim Biophys Acta; 1973 Sep; 321(1):165-70. PubMed ID: 4356302
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of adenosine 3':5'-monophosphate-dependent protein kinases from rabbit skeletal and bovine heart muscle.
    Hofmann F; Beavo JA; Bechtel PJ; Krebs EG
    J Biol Chem; 1975 Oct; 250(19):7795-801. PubMed ID: 170270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of muscle phosphofructokinase by the catalytic subunit of cyclic AMP-dependent protein kinase.
    Riquelme PT; Hosey MM; Marcus F; Kemp RG
    Biochem Biophys Res Commun; 1978 Dec; 85(4):1480-7. PubMed ID: 217388
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding of adenosine 3',5'-monophosphate dependent protein kinase regulatory subunit to immobilized cyclic nucleotide derivatives.
    Dills WL; Beavo JA; Bechtel PJ; Myers KR; Sakai LJ; Krebs EG
    Biochemistry; 1976 Aug; 15(17):3724-31. PubMed ID: 182216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent constants for the interaction of regulatory and catalytic subunit of cAMP-dependent protein kinase I and II.
    Hofmann F
    J Biol Chem; 1980 Feb; 255(4):1559-64. PubMed ID: 6243641
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of protein kinase and phosphoprotein phosphatase by cyclic AMP and cyclic AMP antagonist.
    Wasner HK
    FEBS Lett; 1975 Sep; 57(1):60-3. PubMed ID: 170131
    [No Abstract]   [Full Text] [Related]  

  • 15. 2-substituted derivatives of adenosine and inosine cyclic 3',5'-phosphate. Synthesis, enzymic activity, and analysis of the structural requirements of the binding locale of the 2-substituent on bovine brain protein kinase.
    Meyer RB; Uno H; Robins RK; Simon LN; Miller JP
    Biochemistry; 1975 Jul; 14(15):3315-21. PubMed ID: 167824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium and cyclic AMP-dependent regulation of myofibrillar calmodulin-dependent myosin light chain kinases from cardiac and skeletal muscles.
    Walsh MP; Guilleux JC
    Adv Cyclic Nucleotide Res; 1981; 14():375-90. PubMed ID: 6269389
    [No Abstract]   [Full Text] [Related]  

  • 17. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates.
    Dostmann WR; Taylor SS; Genieser HG; Jastorff B; Døskeland SO; Ogreid D
    J Biol Chem; 1990 Jun; 265(18):10484-91. PubMed ID: 2162349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of casein by cyclic AMP-dependent protein kinase.
    Bingham EW; Groves ML; Szymanski ES
    Biochem Biophys Res Commun; 1977 Feb; 74(4):1332-9. PubMed ID: 191019
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluorescent photoaffinity labeling: adenosine 3',5'-cyclic monophosphate receptor sites.
    Dreyfuss G; Schwartz K; Blout ER; Barrio JR; Liu FT; Leonard NJ
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1199-203. PubMed ID: 206888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the function of the two intrachain cAMP binding sites of protein kinase.
    Rannels SR; Corbin JD
    J Biol Chem; 1981 Aug; 256(15):7871-6. PubMed ID: 6267029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.